23andme Holding Co Share Price Today
(NASDAQ: ME)

Name: 23andme Holding Co Share Price Today (NASDAQ: ME) - 23andme Holding Co Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

23andme Holding Co share price is $1.51 & ₹131.47 as on 6 Mar 2025, 2.30 'hrs' IST

$1.51

▲

0.14

(10.22%)

Market is closed - opens 8 PM, 06 Mar 2025

View live 23andme Holding Co share price in Dollar and Rupees. Guide to invest in 23andme Holding Co stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in 23andme Holding Co, along with analyst recommendations, forecasts, and comprehensive financials.

23andme Holding Co share price movements

Today's Low: $1.35
Today's High: $1.53
$1.51
10.6%
Downside
Day's Volatility :11.76%
Upside
1.31%
52 Weeks Low: $1.34
52 Weeks High: $12.76
$1.51
11.26%
Downside
52 Weeks Volatility :89.5%
Upside
88.17%

23andme Holding Co (ME) Returns

Period	23andme Holding Co	Sector (Health Care)	Index (Russel 2000)
3 Months	-58.17%	3.7%	0.0%
6 Months	-75.73%	-2.8%	0.0%
1 Year	-85.45%	2.5%	0.0%
3 Years	-98.14%	12.9%	-11.6%

23andme Holding Co (ME) Key Statistics

in dollars & INR

Previous Close	$1.37
Open	$1.4
Today's High	$1.53
Today's Low	$1.35
Market Capitalization	$36.8M
Today's Volume	$291.9K
52 Week High	$12.76
52 Week Low	$1.34
Revenue TTM	$208.8M
EBITDA	$-219.7M
Earnings Per Share (EPS)	$-16.09
Profit Margin	-186.98%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-193.76%

How to invest in 23andme Holding Co Stock (ME) from India?

It is very easy for Indian residents to invest directly in 23andme Holding Co from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the 23andme Holding Co stock in both Indian Rupees (INR) and US Dollars (USD). Search for 23andme Holding Co or ME on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of 23andme Holding Co or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of 23andme Holding Co shares which would translate to 0.577 fractional shares of 23andme Holding Co as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like 23andme Holding Co, in just a few clicks!

Returns in 23andme Holding Co (ME) for Indian investors in Rupees

The 23andme Holding Co stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

23andme Holding Co investment value today

Current value as on today

₹19,612

Returns

₹80,388

(-80.39%)

Returns from 23andme Holding Co Stock

₹85,453 (-85.45%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards 23andme Holding Co (ME)

-31%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for 23andme Holding Co Stock from India on INDmoney has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in 23andme Holding Co

Vanguard Group Inc
2.90%
Shay Capital LLC
2.62%
Sapphire Ventures (GPE) I, L.L.C.
0.99%
Jane Street Group LLC
0.96%
BlackRock Inc
0.89%
Millennium Management LLC
0.83%

Analyst Recommendation on 23andme Holding Co

Buy

80%Buy

20%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for 23andme Holding Co(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on 23andme Holding Co Stock (ME)

What analysts predicted

Upside of 37.75%

Target:

$2.08

Current:

$1.51

Insights on 23andme Holding Co Stock (Ticker Symbol: ME)

Price Movement
In the last 7 days, ME stock has moved down by -31.1%
Increasing Revenue
Revenue is up for the last 3 quarters, 40.41M → 60.26M (in $), with an average increase of 17.6% per quarter
Increasing Net Profit
Netprofit is up for the last 5 quarters, -277.97M → -45.53M (in $), with an average increase of 70.3% per quarter
ME vs TMO (1 yr)
In the last 1 year, 23andme Holding Co has experienced a drawdown of -85.4%, however Thermo Fisher Scientific, Inc. resisted the overall trend and outperformed by 74.0%
ME vs TMO (3 yr)
In the last 3 years, 23andme Holding Co has experienced a drawdown of -98.0%, however Thermo Fisher Scientific, Inc. resisted the overall trend and outperformed by 93.8%
Price to Sales
ForME every $1 of sales, investors are willing to pay $0.2, whereas for Thermo Fisher Scientific, Inc., the investors are paying $4.7 for every $1 of sales.

23andme Holding Co Technicals Summary

Sell

Neutral

Buy

23andme Holding Co is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

23andme Holding Co (ME) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
23andme Holding Co	-45.09%	-75.73%	-85.45%	-98.14%	-84.59%
Agilent Technologies Inc.	-13.96%	-8.56%	-13.48%	-2.94%	78.81%
Idexx Laboratories, Inc.	-5.98%	-6.81%	-21.57%	-15.48%	80.06%
Thermo Fisher Scientific, Inc.	-9.71%	-13.63%	-11.38%	-1.97%	77.48%
Danaher Corp.	-2.07%	-20.46%	-16.74%	-19.95%	48.71%
Iqvia Holdings Inc.	-7.09%	-25.1%	-26.53%	-14.22%	49.88%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
23andme Holding Co	NA	NA	NA	0.0	-1.94	-0.33	NA	2.35
Agilent Technologies Inc.	29.02	29.02	2.0	5.57	0.21	0.08	0.01	21.13
Idexx Laboratories, Inc.	41.39	41.39	4.36	11.97	0.58	0.23	NA	19.55
Thermo Fisher Scientific, Inc.	31.65	31.65	2.02	23.33	0.13	0.05	0.0	130.22
Danaher Corp.	38.92	38.92	2.05	7.65	0.08	0.04	0.01	68.9
Iqvia Holdings Inc.	24.81	24.81	0.98	11.89	0.23	0.05	NA	34.45

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
23andme Holding Co	Buy	$36.8M	-84.59%	NA	-186.98%
Agilent Technologies Inc.	Buy	$36.1B	78.81%	29.02	19.27%
Idexx Laboratories, Inc.	Buy	$35.9B	80.06%	41.39	22.78%
Thermo Fisher Scientific, Inc.	Buy	$194.9B	77.48%	31.65	14.77%
Danaher Corp.	Buy	$147.2B	48.71%	38.92	16.33%
Iqvia Holdings Inc.	Buy	$32.8B	49.88%	24.81	8.91%

About 23andme Holding Co

23andMe Holding Co. operates as a consumer genetics testing company in the United States, the United Kingdom, Canada, and internationally. The company operates in two segments, Consumer and Research Services, and Therapeutics. The Consumer and Research Services segment provides personal genome service (PGS) that consists of a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. This segments also operates Lemonaid telehealth platform to access affiliated licensed healthcare professionals for medical consultation and treatment for various common conditions; and offers research services. The Therapeutics segment focuses on the development of novel therapies; and research and development of programs in various therapeutic areas, such as oncology, immunological and inflammatory diseases, and other disease areas, as well as engages in the out-licensing of intellectual property associated with identified drug targets and expenses related to the discovery and development of therapeutic product candidates. This segment also comprises a therapeutics product portfolio, including 23ME-00610 (P006), a humanized monoclonal antibody that interfere with the ability of CD200R1 to interact with CD200 in cancer cells; GSK6097608, an immuno-oncology program for targeting CD96; and 23ME-01473 is an immuno-oncology antibody program that targets the ULBP6 proteins in the NKG2D pathway. The company has collaboration with Mirador Therapeutics to advance mirador's precision medicines for immunology and inflammation. 23andMe Holding Co. was founded in 2006 and is headquartered in South San Francisco, California.

Organization	23andme Holding Co
Employees	560
CEO	Ms. Anne Wojcicki
Industry	Financial

Management People of 23andme Holding Co

Name	Title
Ms. Anne Wojcicki	Co-Founder, CEO, President & Chair of the Board
Mr. Joseph Selsavage	Chief Financial & Accounting Officer
Mr. Guy Chayoun	VP, Interim General Counsel & Corporate Secretary
Ms. Tracy Keim	Chief Marketing Officer
Ms. Savita Pillai	Vice President of People
Mr. Kent Hillyer	Vice President of Consumer Operations
Mr. Daniel Chu	Chief Product Officer
Mr. Frank Russo	Chief Security Officer
Mr. Adam Auton Ph.D.	Vice President of Human Genetics

Important FAQs about investing in ME Stock from India :

What is 23andme Holding Co share price today?

23andme Holding Co share price today stands at $1.51, Open: $1.40 ; Previous Close: $1.37 ; High: $1.53 ; Low: $1.35 ; 52 Week High: $12.76 ; 52 Week Low: $1.34.

The stock opens at $1.40, after a previous close of $1.37. The stock reached a daily high of $1.53 and a low of $1.35, with a 52-week high of $12.76 and a 52-week low of $1.34.

Can Indians buy 23andme Holding Co shares?

Yes, Indians can invest in the 23andme Holding Co (ME) from India.

With INDmoney, you can buy 23andme Holding Co at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy 23andme Holding Co at zero transaction cost.

How can I buy 23andme Holding Co shares from India?

It is very easy to buy 23andme Holding Co from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of 23andme Holding Co (ME) be purchased?

Yes, you can buy fractional shares of 23andme Holding Co with INDmoney app.

What are the documents required to start investing in 23andme Holding Co stocks?

To start investing in 23andme Holding Co, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.